Dialysis easier through Thoratec vascular graft:
This article was originally published in Clinica
Thoratec has asked the FDA for an investigational device exemption to allow it to begin trials of its vascular access graft, a synthetic graft providing access to the bloodstream of dialysis patients. Data from a Japanese study shows the VAG is 91% open to blood flow after 12 months - much higher than competing grafts, says the company. It also permits start of dialysis within three days compared to two weeks.